| Eli Lilly And Company | 657K | US$726M | 12.3% |
| Johnson & Johnson | 2.3M | US$518M | 8.8% |
| Unitedhealth Group Incorporated | 947K | US$360M | 6.1% |
| Merck & Company, Inc. | 2.46M | US$292M | 4.9% |
| Gilead Sciences, Inc. | 1.84M | US$248M | 4.2% |
| Abbvie Inc. | 1.07M | US$233M | 3.9% |
| Amgen Inc. | 590K | US$199M | 3.4% |
| Thermo Fisher Scientific Inc | 362K | US$178M | 3.0% |
| Vertex Pharmaceuticals Incorporated | 362K | US$162M | 2.7% |
| Pfizer, Inc. | 5.9M | US$154M | 2.6% |
| Edwards Lifesciences Corporation | 1.71M | US$148M | 2.5% |
| Danaher Corporation | 645K | US$118M | 2.0% |
| Abbott Laboratories | 1.36M | US$117M | 2.0% |
| Intuitive Surgical, Inc. | 271K | US$115M | 2.0% |
| Teva Pharmaceutical Industries Limited | 3.12M | US$110M | 1.9% |
| Boston Scientific Corporation | 1.95M | US$94M | 1.6% |
| Elevance Health, Inc. | 235K | US$92.4M | 1.6% |
| Argenx Se | 88,995 | US$74.4M | 1.3% |
| Biogen Inc. | 364K | US$71.4M | 1.2% |
| Astrazeneca Plc | 384K | US$71.4M | 1.2% |
| Stryker Corporation | 222K | US$67.7M | 1.1% |
| Revolution Medicines, Inc. | 361K | US$56.9M | 0.96% |
| Humana Inc. | 178K | US$54.4M | 0.92% |
| Regeneron Pharmaceuticals, Inc. | 87,659 | US$53.9M | 0.91% |
| Bristol-myers Squibb Company | 917K | US$52.4M | 0.89% |
| Cogent Biosciences, Inc. | 1.41M | US$49.2M | 0.83% |
| Dexcom, Inc. | 664K | US$48.9M | 0.83% |
| Waters Corporation | 124K | US$47.7M | 0.81% |
| Cytokinetics, Incorporated | 575K | US$44.2M | 0.75% |
| Penumbra, Inc. | 133K | US$42.4M | 0.72% |
| Hca Healthcare, Inc. | 112K | US$42.3M | 0.72% |
| Insmed Incorporated | 392K | US$41.9M | 0.71% |
| Cvs Health Corporation | 460K | US$41.8M | 0.71% |
| Rhythm Pharmaceuticals, Inc. | 471K | US$41.6M | 0.70% |
| Galderma Group Ag | 188K | US$39.8M | 0.67% |
| Incyte Corporation | 396K | US$38.3M | 0.65% |
| Novartis Ag | 252K | US$37.8M | 0.64% |
| Protagonist Therapeutics, Inc. | 370K | US$36.9M | 0.62% |
| Agilent Technologies, Inc. | 271K | US$36.8M | 0.62% |
| Idexx Laboratories, Inc. | 65,102 | US$36.7M | 0.62% |
| Nuvalent, Inc. | 316K | US$34.9M | 0.59% |
| United Therapeutics Corporation | 55,689 | US$31M | 0.53% |
| Alnylam Pharmaceuticals, Inc. | 94,913 | US$28.7M | 0.49% |
| Bruker Corporation | 472K | US$27.8M | 0.47% |
| Moderna, Inc. | 561K | US$26.5M | 0.45% |
| Iqvia Holdings, Inc. | 141K | US$25.7M | 0.44% |
| Illumina, Inc. | 146K | US$23.8M | 0.40% |
| Medline Inc. | 605K | US$22.1M | 0.37% |
| Apogee Therapeutics, Inc. | 264K | US$21.7M | 0.37% |
| Mckesson Corporation | 27,586 | US$20.5M | 0.35% |
| Biomarin Pharmaceutical Inc. | 323K | US$18.5M | 0.31% |
| Neurocrine Biosciences, Inc. | 113K | US$17.9M | 0.30% |
| Dianthus Therapeutics, Inc. | 186K | US$17.3M | 0.29% |
| Roivant Sciences Ltd. | 564K | US$16.9M | 0.29% |
| Quest Diagnostics Incorporated | 85,193 | US$16.6M | 0.28% |
| Lb Pharmaceuticals Inc | 568K | US$15.9M | 0.27% |
| Ucb S.a. | 53,577 | US$15.7M | 0.27% |
| Oruka Therapeutics, Inc. | 265K | US$15.5M | 0.26% |
| Stoke Therapeutics, Inc. | 473K | US$14.6M | 0.25% |
| Arcus Biosciences, Inc. | 572K | US$14.5M | 0.25% |
| Madrigal Pharmaceuticals, Inc. | 27,588 | US$13.7M | 0.23% |
| Ionis Pharmaceuticals, Inc. | 170K | US$13M | 0.22% |
| Cencora, Inc. | 46,310 | US$12.5M | 0.21% |
| Exelixis, Inc. | 232K | US$11.7M | 0.20% |
| Elanco Animal Health Incorporated | 483K | US$11.5M | 0.20% |
| Daiichi Sankyo Company, Limited | 674K | US$11.3M | 0.19% |
| Scholar Rock Holding Corporation | 226K | US$11.2M | 0.19% |
| Kailera Therapeutics, Inc. | 464K | US$10.6M | 0.18% |
| West Pharmaceutical Services, Inc. | 32,517 | US$10.5M | 0.18% |
| Mbx Biosciences, Inc. | 333K | US$10.5M | 0.18% |
| Natera, Inc. | 46,190 | US$10.3M | 0.17% |
| Charles River Laboratories International, Inc. | 56,177 | US$10.2M | 0.17% |
| Bio-techne Corp | 194K | US$10M | 0.17% |
| Novocure Limited | 574K | US$9.79M | 0.17% |
| Intellia Therapeutics, Inc. | 665K | US$9.35M | 0.16% |
| Erasca, Inc. | 710K | US$9.11M | 0.15% |
| Viridian Therapeutics, Inc. | 516K | US$9.09M | 0.15% |
| Glaukos Corporation | 87,150 | US$9.01M | 0.15% |
| Axsome Therapeutics, Inc. | 38,178 | US$8.95M | 0.15% |
| Bright Minds Biosciences Inc. | 95,655 | US$8.42M | 0.14% |
| Agios Pharmaceuticals, Inc. | 272K | US$7.99M | 0.14% |
| Eikon Therapeutics, Inc. | 722K | US$7.83M | 0.13% |
| Vaxcyte, Inc. | 147K | US$7.57M | 0.13% |
| Mettler-toledo International, Inc. | 6,058 | US$7.15M | 0.12% |
| Enanta Pharmaceuticals, Inc. | 492K | US$6.47M | 0.11% |
| Alumis Inc. | 294K | US$6.34M | 0.11% |
| Immunome, Inc. | 289K | US$6.3M | 0.11% |
| Monte Rosa Therapeutics, Inc. | 318K | US$6.27M | 0.11% |
| Bridgebio Oncology Therapeutics, Inc. | 674K | US$6.04M | 0.10% |
| Palvella Therapeutics, Inc. | 50,716 | US$6.01M | 0.10% |
| Radnet, Inc. | 108K | US$6M | 0.10% |
| Bridgebio Pharma, Inc. | 86,968 | US$5.76M | 0.10% |
| Kalvista Pharmaceuticals, Inc. | 213K | US$5.71M | 0.10% |
| Beam Therapeutics Inc. | 168K | US$5.53M | 0.09% |
| Aktis Oncology, Inc. | 267K | US$5.53M | 0.09% |
| Dyne Therapeutics, Inc. | 279K | US$5.39M | 0.09% |
| Denali Therapeutics Inc. | 252K | US$5.3M | 0.09% |
| Maze Therapeutics, Inc. | 184K | US$4.88M | 0.08% |
| Summit Therapeutics Inc. | 277K | US$4.86M | 0.08% |
| Relay Therapeutics, Inc. | 343K | US$4.82M | 0.08% |